Seeking Alpha

Next stop Biogen: Carl Icahn's fight for seats on the board of Biogen Idec (BIIB) comes to a...

Next stop Biogen: Carl Icahn's fight for seats on the board of Biogen Idec (BIIB) comes to a vote Wednesday, June 3. He owns 5.6% of the biotech group. Proxy advisory service RiskMetrics Group is backing two of Icahn's nominees. Icahn gained a seat on Amylin's (AMLN) board this week and is lobbying to ouster top management at Enzon (ENZN).
From other sites
Comments (1)
  • Tony Petroski
    , contributor
    Comments (6368) | Send Message
     
    Icahn. Isn't he the airline guy? Wow! This guy is versatile.
    29 May 2009, 08:29 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs